Drug Shortage Report for DIGIFAB
Report ID | 46307 |
Drug Identification Number | 02361043 |
Brand name | DIGIFAB |
Common or Proper name | Digoxin Immune Fab (Ovine) |
Company Name | BTG INTERNATIONAL INC |
Market Status | MARKETED |
Active Ingredient(s) | DIGOXIN IMMUNE FAB |
Strength(s) | 40MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | One vial |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-04-13 |
Estimated end date | |
Actual end date | 2018-05-04 |
Shortage status | Resolved |
Updated date | 2018-05-05 |
Company comments | Stock released for distribution 04-May-18 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 300 FOUR FALLS CORPORATE CENTER, 300 CONSHOHOCKEN STATE ROAD WEST CONSHOHOCKEN, PENNSYLVANIA UNITED STATES 19428 |
Company contact information | samuel.jenkinson@btgsp.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2018-05-05 | English | Compare |
v12 | 2018-05-04 | French | Compare |
v11 | 2018-05-04 | English | Compare |
v10 | 2018-05-04 | French | Compare |
v9 | 2018-05-04 | English | Compare |
v8 | 2018-04-19 | French | Compare |
v7 | 2018-04-19 | English | Compare |
v6 | 2018-04-19 | French | Compare |
v5 | 2018-04-19 | English | Compare |
v4 | 2018-04-19 | English | Compare |
v3 | 2018-04-19 | English | Compare |
v2 | 2018-04-19 | English | Compare |
v1 | 2018-04-19 | English | Compare |
Showing 1 to 13 of 13